Fractionation and immunologic assessment of KCl-extracted cardiac antigens in coxsackievirus B3 virus-induced myocarditis
- PMID: 221592
Fractionation and immunologic assessment of KCl-extracted cardiac antigens in coxsackievirus B3 virus-induced myocarditis
Abstract
Hypertonic salt extracts prepared from the heart tissues of adolescent CD-1 mice were fractionated on Sephadex G-100 columns. Two separate fractions were obtained. Fraction I, containing the antigenic immunoreactive activity, was able to inhibit the migration of CVB3-PPD immune mouse peritoneal exudate cells (IMPEC) as well as PEC from mice infected with CVB3 virus alone. Fraction II did not have antigenic activity as assessed by the agarose droplet cell migration inhibition assay. As controls, Fraction I prepared from the livers of spleens of CVB3-infected CD-1 mice was unable to inhibit the migration of CVB3 IMPEC. Unimmunized or "normal" mouse peritoneal exudate cells (NMPEC) were not inhibited by Fraction I. Antibodies prepared against Fractions I and II were unable to neutralize CVB3m virus in the plaque reduction test, and polyacrylamide gel analysis revealed multiple bands in 10% SDS gels.
Similar articles
-
Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue.J Immunol. 1978 May;120(5):1672-8. J Immunol. 1978. PMID: 207775
-
Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis.J Immunol. 1995 Mar 15;154(6):2983-95. J Immunol. 1995. PMID: 7533190
-
Coxsackievirus-B3-induced myocarditis: virus receptor antibodies modulate myocarditis.J Immunol. 1989 Sep 15;143(6):1843-50. J Immunol. 1989. PMID: 2550544
-
Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.Infect Immun. 1983 Feb;39(2):851-64. doi: 10.1128/iai.39.2.851-864.1983. Infect Immun. 1983. PMID: 6299950 Free PMC article.
-
Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis.J Immunol. 1986 Sep 1;137(5):1695-702. J Immunol. 1986. PMID: 3018079
Cited by
-
Clinical and experimental aspects of viral myocarditis.Clin Microbiol Rev. 1989 Apr;2(2):191-203. doi: 10.1128/CMR.2.2.191. Clin Microbiol Rev. 1989. PMID: 2650861 Free PMC article. Review.
-
Assessment of cell-mediated immunity against coxsackievirus B3-induced myocarditis in a primate model (Papio papio).Infect Immun. 1981 Jan;31(1):470-9. doi: 10.1128/iai.31.1.470-479.1981. Infect Immun. 1981. PMID: 6260666 Free PMC article.
-
Antimyocarditic activity of the guanine derivative BIOLF-70 in a coxsackievirus B3 murine model.Antimicrob Agents Chemother. 1985 Feb;27(2):184-91. doi: 10.1128/AAC.27.2.184. Antimicrob Agents Chemother. 1985. PMID: 2580480 Free PMC article.
-
Cardiomyopathy and myocarditis--a review of new aspects in research in West Germany.Heart Vessels Suppl. 1985;1:8-13. doi: 10.1007/BF02072351. Heart Vessels Suppl. 1985. PMID: 2956241
-
Coxsackievirus B3 infection alters plasma membrane of neonatal skin fibroblasts.J Virol. 1986 Oct;60(1):294-6. doi: 10.1128/JVI.60.1.294-296.1986. J Virol. 1986. PMID: 3018294 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials